SWK Holdings Corp Liquidation Value Calculator
SWK Holdings Corp
Current Price: N/A
Loading calculator data...
Advanced: All 172 XBRL Tags
Every XBRL tag from SEC EDGAR filings, grouped by financial statement type. total = may include children, fact = independent leaf value.
Balance Sheet
| Tag | Value | Unit | ||
|---|---|---|---|---|
| cash | ||||
| Cash And Cash Equivalents At Carrying Value total CashAndCashEquivalentsAtCarryingValue |
$42.76M | USD | ||
| AI Insight · Cash of $42.8M at December 31, 2025, up from approximately $5.9M at December 31, 2024 (a $36.8M increase per the cash flow statement). The build is attributable to strong collections on finance receivables, asset sales, and partial unwinding of the balance sheet ahead of the pending merger. Cash is the highest-quality liquidation asset at 100% recovery and materially improves the near-term recovery position relative to the prior filing. | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents total CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents |
$42.76M | USD | ||
| current_liabilities | ||||
| Operating Lease Liability Current total OperatingLeaseLiabilityCurrent |
$144,000 | USD | ||
| liabilities_current | ||||
| Liabilities Current total LiabilitiesCurrent |
$4.97M | USD | ||
| liabilities_total | ||||
| Liabilities total | $37.32M | USD | ||
| long_term_debt | ||||
| Debt Instrument Carrying Amount total DebtInstrumentCarryingAmount |
$32.97M | USD | ||
| Long Term Debt total LongTermDebt |
$32.97M | USD | ||
| long_term_investments | ||||
| Investments total | $184,000 | USD | ||
| operating_lease_liability | ||||
| Operating Lease Liability total OperatingLeaseLiability |
$456,000 | USD | ||
| AI Insight · Total operating lease liability of $0.5M ($0.1M current, $0.3M non-current implied) with future payments of $0.2M in year one, $0.2M in year two, and $0.1M in year three. Under liquidation, operating lease commitments do not extinguish and must be settled at face value. The ROU asset is zero on the balance sheet (likely fully amortized or written off post-MOD3 sale), meaning the liability represents an unhedged obligation. The amount is immaterial to the overall recovery analysis. | ||||
| Operating Lease Liability Current fact OperatingLeaseLiabilityCurrent |
$144,000 | USD | ||
| shares_outstanding | ||||
| Common Stock Shares Outstanding total CommonStockSharesOutstanding |
12.1M | shares | ||
Unmapped Tags (156)
| Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent | $4.97M | USD | ||
| Accounts Receivable Net AccountsReceivableNet | $3.86M | USD | ||
| Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | $120,000 | USD | ||
| Additional Paid In Capital AdditionalPaidInCapital | $4.42B | USD | ||
| Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet | $2.23M | USD | ||
| Amortization Of Intangible Assets AmortizationOfIntangibleAssets | $0 | USD | ||
| Assets Assets | $272.42M | USD | ||
| Assets Current AssetsCurrent | $46.79M | USD | ||
| Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent | $0 | USD | ||
| Capitalized Computer Software Gross CapitalizedComputerSoftwareGross | $16,000 | USD | ||
| Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared | $4 | USD/shares | ||
| Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare | $0 | USD/shares | ||
| Common Stock Shares Authorized CommonStockSharesAuthorized | $250.00M | shares | ||
| Common Stock Shares Issued CommonStockSharesIssued | $12.10M | shares | ||
| Common Stock Value CommonStockValue | $12,000 | USD | ||
| Deconsolidation Revaluation Of Retained Investment Gain Or Loss Amount DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount | $-3.73M | USD | ||
| Deferred Tax Assets Gross DeferredTaxAssetsGross | $18.81M | USD | ||
| Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet | $912,000 | USD | ||
| Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards | $9.88M | USD | ||
| Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic | $46.90M | USD | ||
| Deferred Tax Assets Other DeferredTaxAssetsOther | $720,000 | USD | ||
| Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards | $2.99M | USD | ||
| Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch | $3.00M | USD | ||
| Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance | $17.90M | USD | ||
| AI Insight · A $17.9M valuation allowance was recorded as of December 31, 2025, compared to zero allowance at December 31, 2024. This is directly tied to the anticipated Runway Growth Finance Corp merger expected Q2 2026, which management assessed makes realization of federal and state deferred tax assets more likely than not impossible. Under liquidation, deferred tax assets receive a 0% haircut by convention; this $17.9M allowance thus reduces the gross DTA from $18.8M to a net $0.9M on-balance-sheet. The allowance drove $17.9M of the $22.6M total income tax expense for 2025, causing the company to report a consolidated net loss despite pre-tax income of $20.1M. | ||||
| Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets | $5,000 | USD | ||
| Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther | $-14,000 | USD | ||
| Dividends Common Stock DividendsCommonStock | $49.08M | USD | ||
| AI Insight · The company paid $49.1M in common stock dividends during 2025 ($4.00 per share declared), a significant return of capital that reduced the equity base. Under a liquidation lens, this represents cash that exited the estate prior to the measurement date and is not available to satisfy remaining creditors or equity holders. The dividend payment materially reduced the asset base; recovery analysis must be performed on December 31, 2025 balances rather than any pre-dividend balance. | ||||
| Equity Securities Fv Ni Cost EquitySecuritiesFvNiCost | $184,000 | USD | ||
| Equity Securities Fv Ni Current And Noncurrent EquitySecuritiesFvNiCurrentAndNoncurrent | $184,000 | USD | ||
| Equity Securities Fv Ni Unrealized Loss EquitySecuritiesFvNiUnrealizedLoss | $384,000 | USD | ||
| Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization | $143,000 | USD | ||
| Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest | $7.28M | USD | ||
| AI Insight · CECL allowance of $7.3M at December 31, 2025, down from the prior year as provisions were reversed ($924K net benefit for credit losses for 2025 vs. $12.8M provision in 2024). Write-offs during 2025 were $3.0M. The declining reserve reflects portfolio runoff and payoffs rather than improving credit quality across all names; three royalty investments (Best, Ideal, Flowonix) remain impaired. A liquidation analysis should treat the allowance as a floor estimate of credit loss, with additional haircuts warranted given the distressed nature of some underlying obligors. | ||||
| Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss | $218.63M | USD | ||
| AI Insight · Net finance receivables of $218.6M represent approximately 80% of total assets and are the primary recovery driver. Gross balance is $225.9M with a $7.3M CECL allowance. The portfolio is all Level 3, valued at $219.7M fair value per the filing. Compared to the prior 10-Q period (Q3 2025 gross portfolio approximately $253M), the year-end gross balance declined approximately $27M, reflecting payoffs, sales ($31.7M in proceeds from sale of finance receivables per cash flow), and new originations of $28.5M. Under a forced-sale liquidation scenario, achieving par recovery on this bespoke life-science secured debt is not assured; a 85-90% recovery assumption is more appropriate, implying $185-196M in realized value. | ||||
| Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff | $2.97M | USD | ||
| Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss | $225.91M | USD | ||
| Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1 | $-82,000 | USD | ||
| Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases | $38.44M | USD | ||
| Lease Cost LeaseCost | $332,000 | USD | ||
| Leasehold Improvements Gross LeaseholdImprovementsGross | $13,000 | USD | ||
| Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity | $272.42M | USD | ||
| Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent | $0 | USD | ||
| Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments | $-384,000 | USD | ||
| Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss | $-384,000 | USD | ||
| Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent | $218.63M | USD | ||
| Operating Lease Cost OperatingLeaseCost | $278,000 | USD | ||
| Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset | $0 | USD | ||
| Other Assets Current OtherAssetsCurrent | $163,000 | USD | ||
| Other Assets Noncurrent OtherAssetsNoncurrent | $0 | USD | ||
| Other Liabilities Noncurrent OtherLiabilitiesNoncurrent | $240,000 | USD | ||
| Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare | $0 | USD/shares | ||
| Preferred Stock Shares Authorized PreferredStockSharesAuthorized | $5.00M | shares | ||
| Preferred Stock Shares Issued PreferredStockSharesIssued | $0 | shares | ||
| Preferred Stock Shares Outstanding PreferredStockSharesOutstanding | $0 | shares | ||
| Preferred Stock Value PreferredStockValue | $0 | USD | ||
| Property Plant And Equipment Gross PropertyPlantAndEquipmentGross | $168,000 | USD | ||
| Property Plant And Equipment Net PropertyPlantAndEquipmentNet | $48,000 | USD | ||
| Property Plant And Equipment Other PropertyPlantAndEquipmentOther | $0 | USD | ||
| Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit | $-4.18B | USD | ||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | $400,000 | USD | ||
| Stockholders Equity StockholdersEquity | $235.10M | USD | ||
| Unsecured Debt UnsecuredDebt | $32.11M | USD | ||
| AI Insight · The 9.00% Senior Notes due 2027 carry a face value of $32.1M (carrying value net of issuance costs $32.1M per XBRL, gross $33.0M per DebtInstrumentCarryingAmount). These notes are unsecured and subordinate to any secured claims. Under liquidation, these obligations are settled at face value. Maturity is in 2027; no principal is due in the next twelve months per the maturity schedule ($32.97M due in year two). At a 9% coupon on a $32.1M face, the liability is modestly below market if rates have declined; regardless, face-value treatment in liquidation is appropriate. | ||||
| Unsecured Long Term Debt UnsecuredLongTermDebt | $32.11M | USD | ||
| Variable Lease Cost VariableLeaseCost | $54,000 | USD | ||
| Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation | $89,000 | USD | ||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | $1.18M | USD | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | $36.84M | USD | ||
| Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet | $859,000 | USD | ||
| Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet | $912,000 | USD | ||
| Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits | $22.57M | USD | ||
| Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | $277,000 | USD | ||
| Depreciation And Amortization DepreciationAndAmortization | $900,000 | USD | ||
| Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized | $600,000 | USD | ||
| Gain Loss On Sale Of Business GainLossOnSaleOfBusiness | $1.48M | USD | ||
| Gain Loss On Sale Of Notes Receivable GainLossOnSaleOfNotesReceivable | $1.73M | USD | ||
| Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets | $-82,000 | USD | ||
| Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables | $-1.93M | USD | ||
| Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | $1.59M | USD | ||
| Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue | $-1.50M | USD | ||
| Increase Decrease In Derivative Assets And Liabilities IncreaseDecreaseInDerivativeAssetsAndLiabilities | $-915,000 | USD | ||
| Increase Decrease In Financial Instruments Used In Operating Activities IncreaseDecreaseInFinancialInstrumentsUsedInOperatingActivities | $-2.75M | USD | ||
| Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets | $-1.34M | USD | ||
| Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | $183,000 | USD | ||
| Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree | $128,000 | USD | ||
| Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | $188,000 | USD | ||
| Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths | $0 | USD | ||
| Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo | $32.97M | USD | ||
| Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities | $-58.51M | USD | ||
| Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities | $68.06M | USD | ||
| Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities | $27.29M | USD | ||
| Operating Lease Payments OperatingLeasePayments | $400,000 | USD | ||
| Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock | $3.07M | USD | ||
| Payments Of Financing Costs PaymentsOfFinancingCosts | $41,000 | USD | ||
| Payments Of Ordinary Dividends PaymentsOfOrdinaryDividends | $49.08M | USD | ||
| Payments To Acquire Finance Receivables PaymentsToAcquireFinanceReceivables | $28.50M | USD | ||
| Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment | $512,000 | USD | ||
| Proceeds From Derivative Instrument Investing Activities ProceedsFromDerivativeInstrumentInvestingActivities | $1.56M | USD | ||
| Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit | $-6.23M | USD | ||
| Proceeds From Sale Of Finance Receivables ProceedsFromSaleOfFinanceReceivables | $31.68M | USD | ||
| Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment | $110,000 | USD | ||
| Share Based Compensation ShareBasedCompensation | $1.18M | USD | ||
| Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod | $597,401 | shares | ||
| Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue | $3.07M | USD | ||
| Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | $0 | shares | ||
| Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit | $75,000 | USD | ||
| Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit | $22.40M | USD | ||
| Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit | $173,000 | USD | ||
| Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses | $3.35M | USD | ||
| Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss | $119,000 | USD | ||
| Earnings Per Share Basic EarningsPerShareBasic | $-0 | USD/shares | ||
| Earnings Per Share Diluted EarningsPerShareDiluted | $-0 | USD/shares | ||
| Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal | $-999,000 | USD | ||
| General And Administrative Expense GeneralAndAdministrativeExpense | $14.76M | USD | ||
| Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | $20.12M | USD | ||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | $20.12M | USD | ||
| Income Tax Expense Benefit IncomeTaxExpenseBenefit | $22.65M | USD | ||
| Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | $17.92M | USD | ||
| Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | $4.22M | USD | ||
| Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems | $270,000 | USD | ||
| Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes | $120,000 | USD | ||
| Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits | $54,000 | USD | ||
| Interest Expense Debt InterestExpenseDebt | $1.10M | USD | ||
| Interest Expense Operating InterestExpenseOperating | $4.80M | USD | ||
| Net Income Loss NetIncomeLoss | $-2.53M | USD | ||
| Operating Income Loss OperatingIncomeLoss | $20.27M | USD | ||
| Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent | $0 | pure | ||
| Other Operating Income Expense Net OtherOperatingIncomeExpenseNet | $-159,000 | USD | ||
| Research And Development Expense ResearchAndDevelopmentExpense | $1.55M | USD | ||
| Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax | $2.15M | USD | ||
| Revenues Revenues | $41.46M | USD | ||
| Amortization Of Financing Costs AmortizationOfFinancingCosts | $1.35M | USD | ||
| Asset Impairment Charges AssetImpairmentCharges | $641,000 | USD | ||
| AI Insight · Total impairment charges for 2025 were $641K, all in the Pharmaceutical Development and Holding Company segments. This compares to $5.8M in 2024 (primarily Cara Therapeutics intangible). The 2025 charges are modest but confirm that intangible assets and goodwill from the pharmaceutical segment have been substantially written off in prior periods. The pharmaceutical segment now shows zero assets in the segment disclosure, confirming the MOD3 asset sale effectively extinguished that segment's book. | ||||
| Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability | $0 | USD | ||
| Contract With Customer Asset Gross ContractWithCustomerAssetGross | $0 | USD | ||
| Depreciation Depletion And Amortization DepreciationDepletionAndAmortization | $40,000 | USD | ||
| Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet | $-900,000 | USD | ||
| Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax | $1.60M | USD | ||
| Entity Number Of Employees EntityNumberOfEmployees | $9 | employee | ||
| Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants | $-775,000 | USD | ||
| Foreign Currency Transaction Gain Before Tax ForeignCurrencyTransactionGainBeforeTax | $681,000 | USD | ||
| Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax | $-71,000 | USD | ||
| Furniture And Fixtures Gross FurnitureAndFixturesGross | $139,000 | USD | ||
| Interest Paid Net InterestPaidNet | $2.97M | USD | ||
| Long Term Line Of Credit LongTermLineOfCredit | $0 | USD | ||
| Number Of Reportable Segments NumberOfReportableSegments | $2 | segment | ||
| Off Balance Sheet Credit Loss Liability OffBalanceSheetCreditLossLiability | $100,000 | USD | ||
| AI Insight · Unfunded commitments reserve of $0.1M is disclosed, with the prior 10-Q indicating $2.5M in unfunded loan commitments as of September 30, 2025. Under liquidation, unfunded commitments to borrowers do not automatically terminate and could create additional cash obligations depending on the terms of individual credit agreements. The filing does not separately tag the gross unfunded commitment amount in XBRL; the $0.1M reserve is the only tagged value. Filing discusses unfunded commitments in MD&A but does not separately XBRL-tag the gross commitment notional at December 31, 2025. | ||||
| Other Income OtherIncome | $865,000 | USD | ||
| Provision For Other Credit Losses ProvisionForOtherCreditLosses | $-924,000 | USD | ||
| Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives | $775,000 | USD | ||
| Unrecognized Tax Benefits UnrecognizedTaxBenefits | $700,000 | USD | ||
| FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear | $33.24M | USD | ||
| FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear | $42.76M | USD | ||
| FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear | $14.68M | USD | ||
| FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear | $66.07M | USD | ||
| FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear | $38.00M | USD | ||
| ProceedsFromRepaymentsOfAccountsReceivableSecuritization ProceedsFromRepaymentsOfAccountsReceivableSecuritization | $56.91M | USD | ||
| StockIssuedDuringPeriodSharesStockSplits StockIssuedDuringPeriodSharesStockSplits | $8,764 | shares | ||
Showing balance sheet tags only. Liquidation analysis uses balance sheet data.